To test the potential of Hoxa2 to bind Robo2 in vivo, we performed chromatin immunoprecipitation (ChIP) analysis [48] on the selected sites from P19 teratocarcinoma cells, a suitable cell culture system to study Hox-regulated targets (e.g., [43]). The gene discussed is ROBO2; the disease is teratocarcinoma.